Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass. [electronic resource]
Producer: 20050425Description: II274-9 p. digitalISSN:- 1524-4539
- Aged
- Cardiac Surgical Procedures -- mortality
- Cardiopulmonary Bypass -- adverse effects
- Complement Activation -- drug effects
- Complement C3a -- biosynthesis
- Complement Membrane Attack Complex -- biosynthesis
- Double-Blind Method
- Female
- Humans
- Infections -- epidemiology
- Injections, Intravenous
- Intra-Aortic Balloon Pumping -- statistics & numerical data
- Length of Stay -- statistics & numerical data
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Myocardial Ischemia -- etiology
- Prospective Studies
- Receptors, Complement -- administration & dosage
- Sex Factors
- Solubility
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.